Company · CIK 0001599298 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Summit Therapeutics Inc. · SMMT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2026 PForm 4 → | Jun 12, 2:35 pm EDT | Mahkam ZanganehCo-Chief Executive Officer, Director, 10% Owner | 3,810,000 | $13.12 | $49,987,200 | 573,883,879 | +0.67% | |
| Jun 12, 2026 PForm 4 → | Jun 12, 12:28 pm EDT | Robert W DugganCo-Chief Executive Officer, Director, 10% Owner | 3,810,000 | $13.12 | $49,987,200 | 573,883,879 | +0.67% | |
| Jun 4, 2026 PForm 4 → | Jun 4, 6:08 pm EDT | Robert W DugganCo-Chief Executive Officer, Director, 10% Owner | 100,000 | $14.60 | $1,460,000 | 25,824,474 | +0.39% | |
| Jun 4, 2026 PForm 4 → | Jun 4, 5:45 pm EDT | Mahkam ZanganehCo-Chief Executive Officer, Director, 10% Owner | 100,000 | $14.60 | $1,460,000 | 25,824,474 | +0.39% | |
| Jun 4, 2026 PForm 4 → | Jun 4, 4:40 pm EDT | Manmeet Singh SoniCOO and CFO, Director | 50,000 | $14.45 | $722,250 | 3,123,603 | +1.63% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.